Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Diclofenac Potassium.

Client Email

Product

Diclofenac Potassium
CAS 59-48-3
Diclofenac Amide
HEALTH CANADA PATENTS

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Diclofenac Potassium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 11 USDMF, 6 CEP/COS, 4 EU WC, 1 KDMF, 7 NDC API, 20 Listed Suppliers, $ API Reference Price

31 API Suppliers
11 USDMF
6 CEP/COS
4 EU WC
1 KDMF
7 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

104 FDF Dossiers, 24 FDA Orange Book, 20 Europe, 5 Canada, 8 South Africa, 47 Listed Dossiers

104 FDF Dossiers
24 FDA Orange Book
20 Europe
5 Canada
8 South Africa
47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 8 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 15 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 25 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 44 Direct Compression, 33 Disintegrants & Superdisintegrants, 30 Thickeners and Stabilizers, 29 Taste Masking, 28 Controlled & Modified Release, 28 Granulation, 26 Solubilizers, 24 Parenteral, 21 Film Formers & Plasticizers, 21 Co-Processed Excipients, 17 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 15 Topical, 9 Empty Capsules, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Rheology Modifiers, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

96 Fillers, Diluents & Binders
50 Coating Systems & Additives
44 Direct Compression
33 Disintegrants & Superdisintegrants
30 Thickeners and Stabilizers
29 Taste Masking
28 Controlled & Modified Release
28 Granulation
26 Solubilizers
24 Parenteral
21 Film Formers & Plasticizers
21 Co-Processed Excipients
17 Chewable & Orodispersible Aids
16 Lubricants & Glidants
15 Topical
9 Empty Capsules
8 Emulsifying Agents
7 API Stability Enhancers
5 Rheology Modifiers
5 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 6 Finished Drug Prices

3 US Medicaid Prescriptions
6 Finished Drug Prices

MARKET PLACE

19 APIs, 5 FDF Dossiers

19 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 1 US Exclusivities, 1 Health Canada Patents

10 US Patents
1 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 14 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Riches, McKenzie & Herbert LLP

filter Patent Reset all filters

1 All

01 12254144

filter Product Reset all filters

1 All

01 1Diclofenac Potassium

filter Dosage Reset all filters

1 All

01 1Powder for oral solution

filter Exp Date Reset all filters

1 All

01 12017-05-15

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

Riches, McKenzie & Herbert L...

Diclofenac Potassium

AAPS 2024

Not Confirmed

Riches, McKenzie & Herbert LLP

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Diclofenac Potassium

Brand Name : CAMBIA

Patent Number : 2254144

Filing Date : 1997-05-15

Strength per Unit : 50 mg / sachet

Dosage Form : Powder for oral solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?